Fiore, D., Donnarumma, E., Roscigno, G., Iaboni, M., Russo, V., Affinito, A., . . . Condorelli, G. (2016). miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS. Oncotarget.
Dyfyniad Arddull ChicagoFiore, Danilo, et al. "MiR-340 Predicts Glioblastoma Survival and Modulates Key Cancer Hallmarks Through Down-regulation of NRAS." Oncotarget 2016.
Dyfyniad MLAFiore, Danilo, et al. "MiR-340 Predicts Glioblastoma Survival and Modulates Key Cancer Hallmarks Through Down-regulation of NRAS." Oncotarget 2016.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.